Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MOv18IgE |
| Synonyms | |
| Therapy Description |
MOv18IgE is an IgE antibody directed against Folr1, which induces immune response toward Folr1-expressing tumor cells (PMID: 26312875). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MOv18IgE | MOv18 IgE|MOv18-IgE | FOLR1-targeted Therapy 24 | MOv18IgE is an IgE antibody directed against Folr1, which induces immune response toward Folr1-expressing tumor cells (PMID: 26312875). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06547840 | Phase I | MOv18IgE | A Study of MOv18 IgE in Folate Receptor Alpha-expressing Platinum Resistant Ovarian Cancer | Recruiting | GBR | 0 |